相似文献
1
Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.
Clin Infect Dis. 2012 Jun;54(11):1624-7. doi: 10.1093/cid/cis293. Epub 2012 Mar 15.
2
Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
Pediatr Infect Dis J. 2011 Sep;30(9):812-3. doi: 10.1097/INF.0b013e3182154b05.
3
Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
Pediatr Infect Dis J. 2009 Aug;28(8):748-50. doi: 10.1097/INF.0b013e31819bc491.
4
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Clin Pharmacokinet. 2010 Aug;49(8):559-65. doi: 10.2165/11532080-000000000-00000.
5
Linezolid for XDR-TB--Final Study Outcomes.
N Engl J Med. 2015 Jul 16;373(3):290-1. doi: 10.1056/NEJMc1500286.
6
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.
7
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
Eur Respir J. 2012 Apr;39(4):956-62. doi: 10.1183/09031936.00076811. Epub 2011 Sep 29.
8
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10.
9
Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit.
Scand J Infect Dis. 2011 Jul;43(6-7):556-9. doi: 10.3109/00365548.2011.564649. Epub 2011 Mar 10.
10
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
J Antimicrob Chemother. 2012 Feb;67(2):473-7. doi: 10.1093/jac/dkr500. Epub 2011 Dec 1.
引用本文的文献
1
Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients.
Eur J Clin Pharmacol. 2024 Jun;80(6):911-918. doi: 10.1007/s00228-024-03662-0. Epub 2024 Mar 5.
2
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database.
Front Pharmacol. 2024 Feb 16;15:1338902. doi: 10.3389/fphar.2024.1338902. eCollection 2024.
3
Staphylococcal endocarditis in a quadricuspid aortic valve following uncomplicated dengue infection: a case report.
BMC Infect Dis. 2020 Aug 6;20(1):583. doi: 10.1186/s12879-020-05315-w.
4
Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Int J Med Sci. 2019 Oct 15;16(11):1504-1509. doi: 10.7150/ijms.38605. eCollection 2019.
5
Two cases of serious rhabdomyolysis during linezolid treatment.
Infection. 2017 Aug;45(4):563-566. doi: 10.1007/s15010-016-0978-8. Epub 2017 Jan 12.
6
Potential factors involved in the causation of rhabdomyolysis following status asthmaticus.
Allergy Asthma Clin Immunol. 2016 Aug 22;12(1):43. doi: 10.1186/s13223-016-0149-6. eCollection 2016.
7
Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.
Antimicrob Agents Chemother. 2014;58(1):495-502. doi: 10.1128/AAC.01903-13. Epub 2013 Nov 4.
8
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD004795. doi: 10.1002/14651858.CD004795.pub4.
9
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
N Engl J Med. 2012 Oct 18;367(16):1508-18. doi: 10.1056/NEJMoa1201964.
本文引用的文献
1
Clarithromycin significantly increases linezolid serum concentrations.
Antimicrob Agents Chemother. 2010 Dec;54(12):5418-9. doi: 10.1128/AAC.00757-10. Epub 2010 Sep 13.
2
Elevated creatine phosphokinase levels associated with linezolid therapy.
Am J Health Syst Pharm. 2009 Jun 15;66(12):1097-100. doi: 10.2146/ajhp080228.
3
Rhabdomyolysis following clarithromycin monotherapy.
Am J Med Sci. 2009 Jul;338(1):78. doi: 10.1097/MAJ.0b013e31819e221f.
4
Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey.
Diagn Microbiol Infect Dis. 2008 Dec;62(4):407-10. doi: 10.1016/j.diagmicrobio.2008.08.009. Epub 2008 Oct 16.
5
Mitochondrial fatty-acid oxidation disorders.
Semin Pediatr Neurol. 2008 Sep;15(3):140-9. doi: 10.1016/j.spen.2008.05.008.
6
Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.
Chest. 2008 Jul;134(1):187-92. doi: 10.1378/chest.07-1988.
7
Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.
Pharmacology. 2008;82(2):83-8. doi: 10.1159/000134943. Epub 2008 May 27.
8
Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.
Am J Psychiatry. 2007 Feb;164(2):346-7. doi: 10.1176/ajp.2007.164.2.346b.
9
Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia.
Antimicrob Agents Chemother. 2007 Mar;51(3):962-7. doi: 10.1128/AAC.01190-06. Epub 2006 Dec 28.
10
Antituberculosis drugs and hepatotoxicity.
Respirology. 2006 Nov;11(6):699-707. doi: 10.1111/j.1440-1843.2006.00941.x.
Zotero 插件